Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Analyses of Relapsed Cases after Oxaliplatin-Based Adjuvant Chemotherapy for Colorectal Cancer with Cur A Resection].

Yoshimatsu K, Satake M, Sano M, Kodera A, Imaizumi R, Ito Y, Koike T, Yokomizo H, Yano Y, Okayama S, Yamada Y, Asaka S, Usui T, Yamaguchi K, Shiozawa S, Shimakawa T, Katsube T, Naritaka Y.

Gan To Kagaku Ryoho. 2018 Oct;45(10):1519-1520. Japanese.

PMID:
30382064
2.

Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.

Kim HR, Min BS, Kim JS, Shin SJ, Ahn JB, Rho JK, Kim NK, Rha SY.

Oncology. 2011;81(3-4):175-83. doi: 10.1159/000333440. Epub 2011 Nov 3.

PMID:
22057187
3.

Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?

Madbouly KM, Hussein AM, Zeid A.

Dis Colon Rectum. 2013 May;56(5):577-85. doi: 10.1097/DCR.0b013e318286f8fc. Erratum in: Dis Colon Rectum. 2015 Mar;58(3):369.

PMID:
23575396
4.

Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.

Tsuruta A, Yamashita K, Tanioka H, Tsuji A, Inukai M, Yamakawa T, Yamatsuji T, Yoshimitsu M, Toyota K, Yamano T, Nagasaka T, Okajima M.

Drug Des Devel Ther. 2016 Nov 23;10:3827-3835. eCollection 2016.

5.

[Tolerability of Oxaliplatin-Based Adjuvant Chemotherapy for Patients with Colorectal Cancer].

Matsuo H, Nakanishi M, Arita T, Murayama Y, Kuriu Y, Kosuga T, Konishi H, Morimura R, Komatsu S, Shiozaki A, Ikoma H, Ichikawa D, Fujiwara H, Okamoto K, Otsuji E.

Gan To Kagaku Ryoho. 2015 Nov;42(12):2112-4. Japanese.

PMID:
26805281
6.

GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.

Lin WR, Chiang JM, Liang KH, Lim SN, Lai MW, Tsou YK, Hsieh TY, Hsu CK, Yeh CT.

Medicine (Baltimore). 2016 Apr;95(17):e3487. doi: 10.1097/MD.0000000000003487.

7.

Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.

Nakayama I, Suenaga M, Wakatsuki T, Ichimura T, Ozaka M, Takahari D, Shinozaki E, Chin K, Ueno M, Mizunuma N, Yamaguchi T.

Cancer Chemother Pharmacol. 2015 Jul;76(1):133-9. doi: 10.1007/s00280-015-2780-1. Epub 2015 May 21.

PMID:
25994854
8.

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).

Goéré D, Pignon JP, Gelli M, Elias D, Benhaim L, Deschamps F, Caramella C, Boige V, Ducreux M, de Baere T, Malka D.

BMC Cancer. 2018 Aug 6;18(1):787. doi: 10.1186/s12885-018-4697-7.

9.

[Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].

Peng L, Yang W, Zhang Z, Liu H, Hua Y.

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Oct 25;20(10):1168-1173. Chinese.

PMID:
29130233
10.

Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community.

Protásio BM, Matutino A, Lage LV, Santana I, Ramos R, Sabbaga J, Capareli F, Saragiotto D, Riechelmann R, Hoff PM.

Clin Colorectal Cancer. 2017 Mar;16(1):65-72. doi: 10.1016/j.clcc.2016.07.001. Epub 2016 Jul 19.

PMID:
27515842
11.

Large Colorectal Carcinoma Is Predictive of Recurrence After Adjuvant Chemotherapy Using Oxaliplatin.

Nozawa H, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Hata K, Kazama S, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Watanabe T.

Anticancer Res. 2015 Sep;35(9):5073-8.

PMID:
26254409
12.

[Association between RIPK4 relative copy number and prognosis of colorectal cancer patient after oxaliplatin-based chemotherapy].

Peng K, Lin M, Wei Q, Li H, Zhang C, Xie R, Liu Z.

Zhonghua Wei Chang Wai Ke Za Zhi. 2015 Nov;18(11):1111-4. Chinese.

PMID:
26616804
13.

A Study on the Tolerability of Capecitabine plus Oxaliplatin as Adjuvant Chemotherapy.

Nakanishi M, Kuriu Y, Murayama Y, Arita T, Kosuga T, Morimura R, Konishi H, Komatsu S, Shiozaki A, Ikoma H, Ichikawa D, Fujiwara H, Okamoto K, Otsuji E.

Anticancer Res. 2016 Apr;36(4):1851-4.

PMID:
27069169
14.

Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.

Goéré D, Benhaim L, Bonnet S, Malka D, Faron M, Elias D, Lefèvre JH, Deschamps F, Dromain C, Boige V, Dumont F, De Baere T, Ducreux M.

Ann Surg. 2013 Jan;257(1):114-20. doi: 10.1097/SLA.0b013e31827b9005.

PMID:
23235397
15.

Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.

Turan N, Benekli M, Koca D, Ustaalioglu BO, Dane F, Ozdemir N, Ulas A, Oztop I, Gumus M, Ozturk MA, Berk V, Kucukoner M, Uner A, Balakan O, Helvaci K, Ozkan S, Yilmaz U, Buyukberber S; Anatolian Society of Medical Oncology.

Oncology. 2013;84(1):14-21. doi: 10.1159/000342429. Epub 2012 Oct 16.

PMID:
23076023
16.

Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.

Chang MH, Lee IK, Si Y, Lee KS, Woo IS, Byun JH.

Cancer Chemother Pharmacol. 2011 Aug;68(2):317-23. doi: 10.1007/s00280-010-1496-5. Epub 2010 Oct 24.

PMID:
20972872
17.

Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer.

Hsu HC, Chou WC, Shen WC, Wu CE, Chen JS, Liau CT, Lin YC, Yang TS.

Anticancer Res. 2013 Aug;33(8):3317-25.

PMID:
23898098
18.

Adjuvant chemotherapy for the perineural invasion of colorectal cancer.

Suzuki T, Suwa K, Ogawa M, Eto K, Kawahara H, Fujita T, Ikegami M, Yanaga K.

J Surg Res. 2015 Nov;199(1):84-9. doi: 10.1016/j.jss.2015.03.101. Epub 2015 Apr 4.

PMID:
25935467
19.
20.

Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases.

Nishioka Y, Moriyama J, Matoba S, Kuroyanagi H, Hashimoto M, Shindoh J.

Dig Surg. 2018;35(3):187-195. doi: 10.1159/000478791. Epub 2017 Aug 19.

Supplemental Content

Support Center